Marshmallow Extract for Eczema: Why No Significant Difference Is Not Proof of Steroid Equivalence
Marshmallow is the common name of Althaea officinalis, a plant studied in several preparations. A 2021 eczema paper is sometimes described as showing an effect similar to steroids. Its actual design supports a narrower interpretation, particularly when a nonsignificant comparison is being used to suggest that two treatments are interchangeable.
A specific liposomal flower extract
The original 2021 report describes 40 patients in two groups of 20. All received a steroid on the left body side; the right received either 10% liposomal Althaea flower-extract formulation or a base preparation described as eucerin. Steroid choice was hydrocortisone acetate 1% or triamcinolone depending on age. Treatment lasted one month; treatment side was fixed, not randomized.
In the active group, steroids performed better at two weeks. At four weeks, the side comparison was nonsignificant, p=0.716. The report also contains inconsistent person counts: it describes 40 participants but lists 34 males and 46 females. These numbers cannot be treated as 80 independent participants or silently reconciled. No adverse reactions were reported over this short period.
Similarity needs an appropriate test
| Finding or design feature | Interpretation limit |
|---|---|
| p=0.716 at four weeks | Does not, by itself, establish equivalence or noninferiority. |
| Steroid always on the left | Side allocation was not randomized. |
| A 10% liposomal flower preparation | Cannot validate root teas, ordinary creams or different concentrations. |
| Inconsistent participant reporting | The unit of counting requires clarification. |
A usual difference test asks whether the observed data show evidence of a difference. An equivalence or noninferiority study needs a defined acceptable margin and an analysis suited to that question. Failing to find a difference in a small sample is not the same as demonstrating that any possible difference is acceptably small.
Timing also changes the interpretation. A later nonsignificant comparison should not erase an earlier advantage for the steroid side. Someone whose eczema is disrupting sleep may care about the speed of improvement as well as a later score. Our research-reading guide explains why endpoints and comparisons need to stay attached to their measurement times.
The plant name does not identify the product
The preparation involved flower extract encapsulated in liposomes and incorporated into a topical base. That is a formulation process, not a home remedy. A product marketed as marshmallow may use a different plant part, extract, concentration or delivery system. Those differences prevent a citation to this paper from supplying evidence that the new product itself has been tested.
It is also important not to confuse Althaea officinalis with another plant sold under a similar common name. A claim about a related botanical does not reproduce this experiment. Our herbal-treatment evidence article discusses why preparation-specific evidence matters. No findings here establish treatment benefits for a moisturizer that did not contain the studied preparation.
What to discuss before replacing treatment
Bring the exact product label, areas affected, current medicines and treatment timeline to a clinician. Ask whether the proposed change addresses dryness, inflammation, a possible reaction or difficulty maintaining the routine. If there is a need to reduce treatment burden, discuss a supported adjustment rather than making a substitution based on a small trial's nonsignificant result.
The steroid potency guide explains why drug identity, formulation and body site matter. AAD skin-care guidance emphasizes an individualized plan. A study can justify further investigation while remaining insufficient for a personal replacement decision, especially for a child, a large affected area or persistent severe symptoms.
Compare the related evidence
Prepared by the Dr. Arsy editorial team. Sources checked November 9, 2026. Educational information supports discussion with a qualified clinician and does not diagnose or prescribe. The AI-created sports product image is an editorial illustration, not a patient photograph or clinical result.